HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004-2023).

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2025-04-19 DOI:10.1111/hiv.70033
Minyang Xiao, Yuhua Shi, Yunfei Lao, Yanling Ma, Jincheng Lou, Zuyang Zhang, Liru Fu, Yu Han, Junli Huo, Xiaobin Zhang, Yan Guo, Manhong Jia, Jian Li
{"title":"HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004-2023).","authors":"Minyang Xiao, Yuhua Shi, Yunfei Lao, Yanling Ma, Jincheng Lou, Zuyang Zhang, Liru Fu, Yu Han, Junli Huo, Xiaobin Zhang, Yan Guo, Manhong Jia, Jian Li","doi":"10.1111/hiv.70033","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections are global public health concerns. Little research has been conducted on HCV incidence in people with HIV (PWH).</p><p><strong>Methods: </strong>This was a retrospective cohort study to investigate HCV incidence and associated factors in PWH. HCV-negative PWH registered in national HIV databases were enrolled and followed up from 2004 to 2023. Cox proportional hazards models were utilized to identify factors associated with HCV infections.</p><p><strong>Results: </strong>The study followed 50 245 HCV-negative PWH, totaling 272 979.3 person-years (PYs) of observation. We noted an HCV incidence rate of 0.70 per 100 PYs (95% confidence interval (CI) 0.67-0.73). Multivariate analysis indicated that being female (adjusted hazard ratio [aHR] 0.70), married (aHR 0.88), and those involved in homosexual intercourse (aHR 0.57) were associated with a lower risk of HCV infection. Conversely, an increased risk was found among those aged 20-39 years (aHR 2.97), 40-59 years (aHR 3.11), ≥ 60 years (aHR 1.80), treated at county-level antiretroviral therapy (ART) clinics (aHR 1.19), township-level ART clinics (aHR 1.83), those with a history of intravenous drug use (aHR 21.72), and individuals without CD4 testing (aHR 66.05) or HIV viral load testing (aHR 2.09). A 36% relative reduction in HCV transmission (aHR 0.64) was observed from 2010 to 2015, and a 29% relative reduction (aHR 0.71) was noted after 2016 compared with the pre-2010 levels.</p><p><strong>Conclusions: </strong>Despite the decrease in HCV incidence after 2010, achieving HCV elimination in PWH remains challenging. Future endeavours should prioritize improving HCV testing, intervention, and treatment in PWH.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hiv.70033","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections are global public health concerns. Little research has been conducted on HCV incidence in people with HIV (PWH).

Methods: This was a retrospective cohort study to investigate HCV incidence and associated factors in PWH. HCV-negative PWH registered in national HIV databases were enrolled and followed up from 2004 to 2023. Cox proportional hazards models were utilized to identify factors associated with HCV infections.

Results: The study followed 50 245 HCV-negative PWH, totaling 272 979.3 person-years (PYs) of observation. We noted an HCV incidence rate of 0.70 per 100 PYs (95% confidence interval (CI) 0.67-0.73). Multivariate analysis indicated that being female (adjusted hazard ratio [aHR] 0.70), married (aHR 0.88), and those involved in homosexual intercourse (aHR 0.57) were associated with a lower risk of HCV infection. Conversely, an increased risk was found among those aged 20-39 years (aHR 2.97), 40-59 years (aHR 3.11), ≥ 60 years (aHR 1.80), treated at county-level antiretroviral therapy (ART) clinics (aHR 1.19), township-level ART clinics (aHR 1.83), those with a history of intravenous drug use (aHR 21.72), and individuals without CD4 testing (aHR 66.05) or HIV viral load testing (aHR 2.09). A 36% relative reduction in HCV transmission (aHR 0.64) was observed from 2010 to 2015, and a 29% relative reduction (aHR 0.71) was noted after 2016 compared with the pre-2010 levels.

Conclusions: Despite the decrease in HCV incidence after 2010, achieving HCV elimination in PWH remains challenging. Future endeavours should prioritize improving HCV testing, intervention, and treatment in PWH.

中国西南地区HIV感染者的HCV发病率:一项回顾性队列研究(2004-2023)
人类免疫缺陷病毒(HIV)和丙型肝炎病毒(HCV)感染是全球关注的公共卫生问题。关于HIV感染者(PWH)中HCV发病率的研究很少。方法:回顾性队列研究,探讨PWH患者HCV发病率及相关因素。在2004年至2023年期间,对在国家艾滋病毒数据库中登记的hcv阴性PWH进行了登记和随访。使用Cox比例风险模型来确定与HCV感染相关的因素。结果:共随访hcv阴性PWH 50245例,总观察时间272 979.3人年(PYs)。我们注意到HCV的发病率为0.70 / 100 PYs(95%可信区间(CI) 0.67-0.73)。多因素分析显示,女性(校正危险比[aHR] 0.70)、已婚(aHR 0.88)和同性性行为(aHR 0.57)与HCV感染风险较低相关。相反,年龄在20-39岁(aHR 2.97)、40-59岁(aHR 3.11)、≥60岁(aHR 1.80)、在县级抗逆转录病毒治疗诊所(aHR 1.19)、乡级抗逆转录病毒治疗诊所(aHR 1.83)、有静脉注射吸毒史(aHR 21.72)和未进行CD4检测(aHR 66.05)或HIV病毒载量检测(aHR 2.09)的人群发生风险增加。2010年至2015年,HCV传播相对下降36% (aHR 0.64), 2016年之后与2010年之前的水平相比,HCV传播相对下降29% (aHR 0.71)。结论:尽管2010年后HCV发病率有所下降,但在PWH中实现HCV消除仍然具有挑战性。未来的工作应优先考虑改善PWH的HCV检测、干预和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信